Paper39697473
Bioadhesive hybrid system of niosomes and pH sensitive in situ gel for itraconazole ocular delivery: Dual approach for efficient treatment of fungal infections.
Badran MM and 6 others. Saudi Pharm J, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Bioadhesive hybrid system of niosomes and pH sensitive in situ gel for itraconazole ocular delivery: Dual approach for efficient treatment of fungal infections. Papers, record 39697473. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39697473
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioadhesive hybrid system of niosomes and pH sensitive in situ gel for itraconazole ocular delivery: Dual approach for efficient treatment of fungal infections.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25819360 | Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by Layer-by-Layer electrostatic deposition for quercetin delivery. | Colloids Surf B Biointerfaces | 2015 | https://conductscience.org/library/papers/25819360 | PubMed |
| 2 | 35869684 | Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, in vitro characterization, and in vivo pharmacodynamic evaluation in rabbits. | Drug Deliv | 2022 | https://conductscience.org/library/papers/35869684 | PubMed |
| 3 | 35271644 | Comparative statistical analysis of the release kinetics models for nanoprecipitated drug delivery systems based on poly(lactic-co-glycolic acid). | PLoS One | 2022 | https://conductscience.org/library/papers/35271644 | PubMed |
| 4 | 32570885 | Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects. | Nanomaterials (Basel) | 2020 | https://conductscience.org/library/papers/32570885 | PubMed |
| 5 | 29130758 | Proniosomes derived niosomes: recent advancements in drug delivery and targeting. | Drug Deliv | 2017 | https://conductscience.org/library/papers/29130758 | PubMed |
| 6 | 33910737 | Hyaluronic acid in ocular drug delivery. | Carbohydr Polym | 2021 | https://conductscience.org/library/papers/33910737 | PubMed |
| 7 | 35002390 | Itraconazole loaded nano-structured lipid carrier for topical ocular delivery: Optimization and evaluation. | Saudi J Biol Sci | 2022 | https://conductscience.org/library/papers/35002390 | PubMed |
| 8 | 29371573 | Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. | J Fungi (Basel) | 2017 | https://conductscience.org/library/papers/29371573 | PubMed |
| 9 | 30651728 | Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier. | Adv Pharmacol Sci | 2018 | https://conductscience.org/library/papers/30651728 | PubMed |
| 10 | 32551978 | Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. | Drug Deliv | 2020 | https://conductscience.org/library/papers/32551978 | PubMed |
| 11 | 36216174 | Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review. | J Control Release | 2022 | https://conductscience.org/library/papers/36216174 | PubMed |
| 12 | 27085041 | Preparation of novel capsosome with liposomal core by layer-by-Layer self-assembly of sodium hyaluronate and chitosan. | Colloids Surf B Biointerfaces | 2016 | https://conductscience.org/library/papers/27085041 | PubMed |
| 13 | 34119171 | Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration. | Carbohydr Polym | 2021 | https://conductscience.org/library/papers/34119171 | PubMed |
| 14 | 30815384 | Proniosomal gel-mediated topical delivery of fluconazole: Development, in vitro characterization, and microbiological evaluation. | J Adv Pharm Technol Res | 2019 | https://conductscience.org/library/papers/30815384 | PubMed |
| 15 | 34588852 | Formulation development and evaluation of lidocaine hydrochloride loaded in chitosan-pectin-hyaluronic acid polyelectrolyte complex for dry socket treatment. | Saudi Pharm J | 2021 | https://conductscience.org/library/papers/34588852 | PubMed |
| 16 | 34760014 | Characterization and distribution of niosomes containing ursolic acid coated with chitosan layer. | Res Pharm Sci | 2021 | https://conductscience.org/library/papers/34760014 | PubMed |
| 17 | 36286136 | Novel Metoprolol-Loaded Chitosan-Coated Deformable Liposomes in Thermosensitive In Situ Gels for the Management of Glaucoma: A Repurposing Approach. | Gels | 2022 | https://conductscience.org/library/papers/36286136 | PubMed |
| 18 | 38667685 | Development and Characterization of Thermosensitive and Bioadhesive Ophthalmic Formulations Containing Flurbiprofen Solid Dispersions. | Gels | 2024 | https://conductscience.org/library/papers/38667685 | PubMed |
| 19 | 35577828 | Antimicrobial properties of chitosan from different developmental stages of the bioconverter insect Hermetia illucens. | Sci Rep | 2022 | https://conductscience.org/library/papers/35577828 | PubMed |
| 20 | 33747850 | A Review on Ocular Novel Drug Delivery Systems of Antifungal Drugs: Functional Evaluation and Comparison of Conventional and Novel Dosage Forms. | Adv Pharm Bull | 2021 | https://conductscience.org/library/papers/33747850 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42761635 | Formulation-Driven Innovation in Antifungal Therapy: From Nanotechnology to AI-Assisted Design. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42761635 | PubMed |
| 42376636 | Surfactant-Engineered Niosomal Antibiotic Systems for Biofilm-Associated Infections: Design Principles and Translational Perspectives. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42376636 | PubMed |
| 41741764 | Bridging Gaps in Fungal Keratitis Management: Novel Diagnostics, Drug Delivery Systems, and Gene Therapies. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/41741764 | PubMed |
| 41080678 | Comprehensive insights into the role of nanocarriers in advancing azole-based ocular therapeutics. | RSC Adv | 2025 | https://conductscience.org/library/papers/41080678 | PubMed |
| 40508808 | A State-of-the-Art Review on Recent Biomedical Application of Polysaccharide-Based Niosomes as Drug Delivery Systems. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/40508808 | PubMed |
| 40276153 | Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization. | Nanoscale Adv | 2025 | https://conductscience.org/library/papers/40276153 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39697473
GET https://conductscience.org/api/papers/v1/39697473/references?page=2